LakeShore Biopharma Co Profit Margin

LakeShore Biopharma Co's profit margin stands at -66.9% as of March 2024. That compares with 12.79% in the prior-year period — down 623.2% year over year. That is below the sector sector average of 19.72%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

LakeShore Biopharma Co reported -66.9% in profit margin versus 12.79% a year earlier — a 623.2% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

LakeShore Biopharma Co sits lower the its sector benchmark (19.72%) with a profit margin of -66.9%. That is roughly 439.2% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of -66.9% for LakeShore Biopharma Co means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how LakeShore Biopharma Co's profit margin evolved across reporting periods, while the comparison chart places LSB next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.